NET PROFIT (x1000 DKK)
EMPLOYEES
Billev Pharma ApS
Closing information (x1000 DKK)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
4,342
|
6,342
|
7,721 |
| Total assets |
6,911
|
8,946
|
10,362 |
| Current assets |
6,896
|
8,944
|
10,356 |
| Current liabilities |
2,532
|
2,234
|
2,461 |
| Equity capital |
3,699
|
5,263
|
6,333 |
| - share capital |
320
|
320
|
320 |
| Employees (average) |
15
|
15
|
15 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
53.5%
|
58.8%
|
61.1% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
272.4%
|
400.4%
|
420.8% |
| Return on equity (ROE) |
117.4%
|
120.5%
|
121.9% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.